These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

180 related articles for article (PubMed ID: 37142967)

  • 1. Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma.
    Zou R; Zhong X; Liang K; Zhi C; Chen D; Xu Z; Zhang J; Liao D; Lai M; Weng Y; Peng H; Pang X; Ji Y; Ke Y; Zhang H; Wang Z; Wang Y
    BMC Cancer; 2023 May; 23(1):403. PubMed ID: 37142967
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated TYROBP expression predicts poor prognosis and high tumor immune infiltration in patients with low-grade glioma.
    Lu J; Peng Y; Huang R; Feng Z; Fan Y; Wang H; Zeng Z; Ji Y; Wang Y; Wang Z
    BMC Cancer; 2021 Jun; 21(1):723. PubMed ID: 34162355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. GPR37 expression as a prognostic marker in gliomas: a bioinformatics-based analysis.
    Liang K; Guo Z; Zhang S; Chen D; Zou R; Weng Y; Peng C; Xu Z; Zhang J; Liu X; Pang X; Ji Y; Liao D; Lai M; Peng H; Ke Y; Wang Z; Wang Y
    Aging (Albany NY); 2023 Oct; 15(19):10146-10167. PubMed ID: 37837549
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte immunoglobulin-like receptor subfamily B member 1 potentially acts as a diagnostic and prognostic target in certain subtypes of adenocarcinoma.
    Cheng J; Gao X; Zhang X; Guo H; Chen S; Gou X
    Med Hypotheses; 2020 Nov; 144():109863. PubMed ID: 32534335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High LYRM4-AS1 predicts poor prognosis in patients with glioma and correlates with immune infiltration.
    Wang HY; Xie Y; Du H; Luo B; Li Z
    PeerJ; 2023; 11():e16104. PubMed ID: 37810780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. EFNA1 is a potential key gene that correlates with immune infiltration in low-grade glioma.
    Hao YP; Wang WY; Qiao Q; Li G
    Medicine (Baltimore); 2021 Jun; 100(22):e26188. PubMed ID: 34087884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LILRB1
    Xu X; Yin S; Wang Y; Zhu Q; Zheng G; Lu Y; Li T; Zhu C
    Int Immunopharmacol; 2023 Jun; 119():110162. PubMed ID: 37075669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selenoprotein GPX1 is a prognostic and chemotherapy-related biomarker for brain lower grade glioma.
    Chen X; Fu G; Li L; Zhao Q; Ke Z; Zhang R
    J Trace Elem Med Biol; 2022 Dec; 74():127082. PubMed ID: 36155420
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PLEKHA4 Is a Prognostic Biomarker and Correlated with Immune Infiltrates in Glioma.
    Zhang W; Li L; Bian PP; Luo QP; Xiong ZT
    Biomed Res Int; 2023; 2023():4504474. PubMed ID: 36714030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Poor Prognosis and Therapeutic Responses in LILRB1-Expressing M2 Macrophages-Enriched Gastric Cancer Patients.
    Zhang Y; Wang H; Xu X; Liu H; Hao T; Yin S; Zhang C; He Y
    Front Oncol; 2021; 11():668707. PubMed ID: 34485116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis-related gene signature correlates with the tumor immune features and predicts the prognosis of glioma patients.
    Hu Y; Tu Z; Lei K; Huang K; Zhu X
    Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34726238
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SARS-CoV-2 Pattern Provides a New Scoring System and Predicts the Prognosis and Immune Therapeutic Response in Glioma.
    Jiang F; Lu DF; Zhan Z; Yuan GQ; Liu GJ; Gu JY; Sun XO; Wang Z
    Cells; 2022 Dec; 11(24):. PubMed ID: 36552760
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and validation of transferrin receptor protein 1 for predicting prognosis and immune infiltration in lower grade glioma.
    Wu H; He H; Huang J; Wang C; Dong Y; Lin R; Cheng Z; Qiu Q; Hong L
    Front Mol Neurosci; 2022; 15():972308. PubMed ID: 36483569
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Systematic Landscape of Nectin Family and Nectin-Like Molecules: Functions and Prognostic Value in Low Grade Glioma.
    Han Y; Zou C; Zhu C; Liu T; Shen S; Cheng P; Cheng W; Wu A
    Front Genet; 2021; 12():718717. PubMed ID: 34925438
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor mutational burden is associated with poor outcomes in diffuse glioma.
    Wang L; Ge J; Lan Y; Shi Y; Luo Y; Tan Y; Liang M; Deng S; Zhang X; Wang W; Tan Y; Xu Y; Luo T
    BMC Cancer; 2020 Mar; 20(1):213. PubMed ID: 32164609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interferon gamma-related gene signature based on anti-tumor immunity predicts glioma patient prognosis.
    Zhang Z; Shen X; Tan Z; Mei Y; Lu T; Ji Y; Cheng S; Xu Y; Wang Z; Liu X; He W; Chen Z; Chen S; Lv Q
    Front Genet; 2022; 13():1053263. PubMed ID: 36712869
    [No Abstract]   [Full Text] [Related]  

  • 17. MCM4 is a novel prognostic biomarker and promotes cancer cell growth in glioma.
    Yang S; Yuan Y; Ren W; Wang H; Zhao Z; Zhao H; Zhao Q; Chen X; Jiang X; Zhang L
    Front Oncol; 2022; 12():1004324. PubMed ID: 36465369
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deciphering the role of QPCTL in glioma progression and cancer immunotherapy.
    Liu Y; Lu S; Sun Y; Wang F; Yu S; Chen X; Wu LL; Yang H; Shi Y; Zhao K
    Front Immunol; 2023; 14():1166377. PubMed ID: 37063864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECM2, a prognostic biomarker for lower grade glioma, serves as a potential novel target for immunotherapy.
    Cheng X; Liu Z; Liang W; Zhu Q; Wang C; Wang H; Zhang J; Li P; Gao Y
    Int J Biochem Cell Biol; 2023 May; 158():106409. PubMed ID: 36997057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of the expression and prognosis for leukocyte immunoglobulin-like receptor subfamily B in human liver cancer.
    Fan J; Wang L; Chen M; Zhang J; Li J; Song F; Gu A; Yin D; Yi Y
    World J Surg Oncol; 2022 Mar; 20(1):92. PubMed ID: 35321724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.